Call our 24 hours, seven days a week helpline at 800.272.3900
Let us connect you to professionals and support options near you. Please select an option below:
Use Current LocationUse Map Selector
In the News | HealthDay
In the News | Washington Post
In the News | NPR.org
In the News | AARP.org
In the News | MedPage Today
In the News | IFL Science
In the News | Medical News Today
In the News | Being Patient
In the News | Forbes
In the News | USA Today
In the News | Everyday Health
In the News | Reuters
In the News | New York Times
In the News | Eat This, Not That
In the News | The Hill
Actress and Caregiver Knows the Devastation of Alzheimer’s
Brain Donation Helps Researchers Continue the Fight Against Alzheimer’s
NASCAR Driver Ryan Blaney Raises $650,000 Through Custom Car Auction
Caregiving Is a Multigenerational Effort for Many Latino Families
New Studies Show Some Vaccines May Lower Alzheimer’s Risk
When Driving Becomes Dangerous, Difficult Conversations are a Must
In the News | The Smithsonian
In the News | Associations Now
Annual report shows more than 6 million Americans are living with Alzheimer’s
Alzheimer’s Association, AIM Endorse Alzheimer’s Caregiver Support Act
In the News | NextAvenue
In the News | AARP
In the News | Diversity Inc.
Reminds families to remain diligent in wake of recent CMS and CDC guidelines to expand visitation
In the News | CNN
Funding will help expand the Dominantly Inherited Alzheimer’s Network Trials Unit to include anti-tau drugs
Training and exam are aimed at implementing latest evidenced-based practices to ensure quality dementia care for a growing number of Americans
In the News | McKnight’s Long-Term Care News
The Alzheimer’s Association looks forward to learning full details related to the decision from the FDA and the company in the weeks to come.
The Comprehensive Care for Alzheimer's Act Endorsed by Alzheimer’s Association, Alzheimer’s Impact Movement
In the News | Cerebrum by Dana Foundation
Maria C. Carrillo, Ph.D., Chief Science Officer at the Alzheimer’s Association, has been appointed to the International Brain Bee (IBB) Board of Directors.
In the News | Discover Magazine
In the News | Kaiser Health News
Bipartisan Legislation to Support Equity in Alzheimer’s Clinical Trials Endorsed by Alzheimer’s Association, Alzheimer’s Impact Movement
June is Alzheimer’s and Brain Awareness Month
The Alzheimer’s Association enthusiastically welcomes today’s historic FDA approval of aducanumab (Biogen/Eisai) for treatment of Alzheimer’s disease.
As the global nonprofit leader in Alzheimer’s research and science we have extensively reviewed the clinical trial data for AduhelmTM (aducanumab).
Leading voices in the Alzheimer’s and dementia scientific community underscored that Aduhelm™ (aducanumab) be made available to the population who may benefit.
The Alzheimer’s Association and the National Hispanic Medical Association (NHMA) are partnering to increase concern and awareness of Alzheimer’s disease and all
The Alzheimer’s Association is pleased with the announcement today that the FDA has revised the prescribing label for Aduhelm™ (aducanumab).
Aduhelm has been approved for use for those with Mild Cognitive Impairment
(MCI) or early stage Alzheimer’s dementia.
We welcome today’s announcement of a National Coverage Determination (NCD) analysis, consistent with the Alzheimer’s Association position.
A House appropriations subcommittee proposed a $200 million increase in Alzheimer’s/dementia research funding and $19.5 million for BOLD.
NIH requests $226 million funding increase for fiscal year 2023
Actor on His Mom’s Struggle with the Disease and His Family’s Advocacy
Studies Link Formal Education to Reduced Risk of Alzheimer's
Olympians Personally Impacted by Alzheimer’s
Dementia Presents Unique Challenges for Native Peoples
How to Disclose — or React to — a Dementia Diagnosis
Some Researchers Fight Alzheimer’s In and Out of the Lab
Improving air quality may improve cognitive function and reduce dementia risk, according to several studies reported today at AAIC® 2021.
The Association is thrilled to recognize these researchers for the important contributions they have made to the field of Alzheimer’s and dementia research.
New analysis shows a decrease in prevalence due to education, countered by increase due to heart health risk factors, as reported at AAIC 2021.
Transgender and gender nonbinary adults are more likely to report worsening cognitive limitations and mental health, according to studies reported at AAIC 2021.
Take the Brain Tour